Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks

Conclusions:
Teriparatide was associated with less pain and a shorter time to complete the TUG test between 6 and 26 weeks compared with risedronate. Other fracture-recovery outcomes were similar. The results should be interpreted with caution as these were secondary end points.

Level of Evidence:
Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Source: JBJS - November 15, 2016 Category: Orthopaedics Authors: Aspenberg, P., Malouf, J., Tarantino, U., Garcia-Hernandez, P. A., Corradini, C., Overgaard, S., Stepan, J. J., Borris, L., Lespessailles, E., Frihagen, F., Papavasiliou, K., Petto, H., Caeiro, J. R., Marin, F. Tags: Trauma Scientific Articles Source Type: research